Wordt geladen...
Bromocriptine and insulin sensitivity in lean and obese subjects
Bromocriptine is a glucose-lowering drug, which was shown to be effective in obese subjects with insulin resistance. It is usually administered in the morning. The exact working mechanism of bromocriptine still has to be elucidated. Therefore, in this open-label randomized prospective cross-over mec...
Bewaard in:
| Gepubliceerd in: | Endocr Connect |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bioscientifica Ltd
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097144/ https://ncbi.nlm.nih.gov/pubmed/27758845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-16-0051 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|